Video and artwork by Leah Bury
The Devlin lab at Harvard Medical School uses strategies from chemical biology to study the human microbiome. Our goal is to control the chemistry of human-associated bacteria in order to understand how the microbiome affects human health and disease. The lab leverages expertise from different fields, including synthetic organic chemistry, molecular biology, microbiology, analytical chemistry, and bioinformatics.
The Devlin lab would be a good fit for students and post-docs with either (1) an organic or analytical chemistry background interested in using chemistry to study biological problems or (2) a microbiology, biochemistry, or cell biology background interested in studying the human microbiome. If you are interested, get in touch.
CURRENT OPENINGS: The Devlin lab has openings for postdoctoral fellows (current as of September 27, 2021). Candidates with backgrounds in chemical biology, cell biology, chemistry (particularly analytical chemistry/mass spectrometry), or microbiology are encouraged to apply. Interested candidates should email Professor Devlin directly.
Our lab provides a welcoming and supportive environment in which to do science, and Professor Devlin supports postdocs interested in a range of career trajectories.
September 2021: We are excited to welcome Melissa Tran to the lab!
July 2021: We said goodbye to Lina, who is starting a new position at Genentech!
June 2021: We are excited to welcome Jasmine Walsh to the lab!
April 2021: We said goodbye to Ari, who is starting a new position at Senda Biosciences!
February 2021: Sloan has received an Alfred P. Sloan fellowship in chemistry – congrats to the whole lab on this accomplishment!
March 2020: We are excited to welcome Gabriel D’Agostino to the lab! We also transitioned to a work-from-home format this month as an effort to practice social distancing and combat the COVID19 pandemic.
January 2020: We welcome Chelsea Powell to the lab as a new post-doctoral fellow. Welcome, Chelsea! We also welcome two rotation students from the Harvard Chemical Biology PhD program, Gabriel and Farah, who will be joining us for the next few weeks. Also, our second pre-print was posted on BioRxiv, titled “Bariatric surgery reveals a gut-restricted TGR5 agonist that exhibits anti-diabetic effects.” [link]